Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Comparing Two Skin Incisions for Flexor Tendon Repair

19 maggio 2026 aggiornato da: Anders Bjorkman, Sahlgrenska University Hospital

Prospective Randomized Controlled Trial to Compare Bruner Incision With Modified Midlateral Bruner Incision for Flexor Tendon Repair

Flexor tendons injuries in the fingers are common and often require surgery. During surgery, the surgeon needs to make an incision in the skin on the inside of the finger to access the damaged tendon.

A comparison will be done between two types of skin incisions in the fingers:

  • Bruner zig-zag incision
  • modified Bruner midlateral zig-zag incision

Research questions:

  • Is there a difference in pain between the types of incisions?
  • Is there a difference in swelling between the types of incisions?
  • Does the type of incision affect the final result in term of motion?

Patients who will undergo surgery for a flexor tendon injury in a finger will be asked to participate and be randomized to one type of skin incision. All other parts of the surgery will be carried out as usual.

An occupational therapist and nurse will measure swelling and motion. The participant will report pain on a daily basis.

The results for pain, swelling, motion in the fingers and sensibility in the fingers will be statistically compared between the two types of incisions on a group level.

The results of this study may lead to guidelines for skin incisions in acute flexor tendon repair, allowing patients to experience less pain and swelling. This may facilitate the rehabilitation program and improve the final functional outcome.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Background and Purpose Tendon injuries are a common type of hand trauma, with flexor tendon injuries most often occurring in zone II. Careful surgical technique followed by early, intensive mobilization under the supervision of a hand therapist is of utmost importance. The traditional Bruner incision, a zig-zag incision, provides wide exposure. However, it also causes extensive soft tissue trauma, leading to swelling and pain, which in turn may reduce adherence to hand rehabilitation protocols. The modified Bruner incision is an alternative approach in which the incision is placed along the lateral side of the finger and slightly curved volarly toward the midpoint between the flexion creases, without crossing the volar midline. This approach provides adequate exposure of the flexor tendon and the digital neurovascular structures with less dissection. Clinical experience suggests that the modified Bruner incision may result in less swelling and pain, faster wound healing and improved conditions for early mobilization. However, there is currently a lack of studies comparing clinical outcomes between the traditional Bruner incision and the modified Bruner incision.

The aim of this study is to investigate whether there are differences in swelling, pain and functional outcomes between patients undergoing flexor tendon repair using the traditional Bruner incision versus the modified Bruner incision.

Research Questions

In primary repair of zone II flexor tendon injuries:

  1. Do patients treated with a modified Bruner incision experience less postoperative pain during the first three months after surgery?
  2. Do fingers operated on using a modified Bruner incision demonstrate reduced swelling during the first three postoperative months?
  3. Do fingers repaired with a modified Bruner incision show improved range of motion during the first three postoperative months?

Methods A randomized controlled study conducted at the Department of Hand Surgery, Mölndal Hospital.

Eligible patients with acute flexor tendon injuries will be invited to participate. After providing informed consent, participants will be randomised to undergo either a standard Bruner incision or a modified midlateral Bruner incision, with all other operative and perioperative variables standardised between the groups.

All procedures will be performed by either a specialist in hand surgery or a hand surgery resident. Within three days postoperatively, at the first dressing change, patients will be assessed by an occupational therapist.

Follow-up evaluations will be conducted at fixed time points: 2, 4, 6, 8, and 12 weeks after surgery. Wound healing will be monitored weekly by a nurse until complete healing has been achieved.

Outcome Measures

Primary outcome

  • Pain during exercise, measured using the Visual Analogue Scale (VAS) 0-10; assessed on postoperative day 3 and thereafter daily for 3 months postoperatively (REDCap questionnaire) Secondary outcomes
  • Resting pain
  • Daily use of analgesics (REDCap questionnaire)
  • Swelling: circumference of the injured finger / circumference of the contralateral finger (OT)
  • Range of motion: Total Passive Motion (TPM) and Total Active Motion (TAM) of the injured finger / TPM and TAM of the contralateral finger (OT)
  • Fingertip sensibility: Semmes-Weinstein monofilament testing (OT), two-point discrimination (physician)
  • Extension deficit of the proximal and distal interphalangeal joints (PIP and DIP) (OT)
  • Wound healing: Surgical Wound Assessment Tool (SWAT) (nurse)
  • Length of the skin incision (cm); a photograph of the incision pattern is obtained intraoperatively

Independent Variables

  • Sex
  • Age
  • Systemic disease: diabetes mellitus, vascular disease, chronic obstructive pulmonary disease (COPD)
  • Occupation
  • Occupational injury Yes/No
  • Mechanism of injury
  • Number of injured fingers
  • Digital nerve injury
  • Type of anesthesia
  • Type of suture
  • Type of rehabiliation protocol
  • Complications: wound infection, suture rupture, conversion of incision

Data Sources Data will be recorded in eCRF using REDCap. Patients will report daily, at predefined time points, VAS pain scores and number of analgesic tablets taken the same day through mobile-based questionaries.

Statistical Analysis The primary outcome measure is pain during exercise, where a between-group difference of 2 points is considered clinically relevant. Assuming a significance level of p < 0.05 and an estimated standard deviation of 2.5 points, the required sample size is calculated to be 26 patients per group to achieve 80% power. To compensate for potential dropouts, a total of 70 patients will be included (35 in each group). Differences in pain, swelling and range of motion at different time points will be compared using bivariate analyses.

Ethics Participation in the study does not involve any change in standard care, except for the surgical incision, which differs between two established methods, the Bruner incision and the modified Bruner incision. Both incision types are standard treatments and have been in clinical use for many years. All patients will receive oral and written information and provide informed consent before inclusion. Participation is voluntary and may be discontinued at any time without affecting the patient's care. Collected data will be pseudonymized and stored securely in locked storage.

Clinical Benefit The results of this study may lead to evidence-based guidelines for skin incisions in acute flexor tendon repair, allowing patients to experience less pain and swelling. This may facilitate the postoperative rehabilitation program and improve the final functional outcome.

Tipo di studio

Interventistico

Iscrizione (Stimato)

70

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • flexor tendon injury in the hand in zone 2

Exclusion Criteria:

  • complex injuries with fracture and/or skin defect
  • previous injury with functional deficit of the finger or the contralateral control finger
  • incapable to follow the training protocol for flexor tendon injuries
  • not proficient in swedish or english language
  • active substance abuse

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Bruner
Traditional Bruner skin incision
Two different types of skin incisions will be compared for patients needing flexor tendon repair in the finger.
Comparatore attivo: Modified Bruner
Modified midlateral Bruner skin incision
Two different types of skin incisions will be compared for patients needing flexor tendon repair in the finger.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
pain with exercise
Lasso di tempo: from day 3 after surgery, daily until 3 months after surgery
Visual Analogue scale from 0 to 10. 0 = is no pain at all; 10 = the worst pain
from day 3 after surgery, daily until 3 months after surgery

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
pain medication
Lasso di tempo: from day 3 after surgery until 3 months after surgery
use of pain medication, opioids/non-opioids
from day 3 after surgery until 3 months after surgery
swelling
Lasso di tempo: at 2, 4, 6, 8, 12 weeks
fingers circumferens in mm
at 2, 4, 6, 8, 12 weeks
range of motion
Lasso di tempo: at 2, 4, 6, 8, 12 weeks
total active motion of the finger
at 2, 4, 6, 8, 12 weeks
sensation SW
Lasso di tempo: at 8 weeks
Semmes-Weinstein in the fingertip
at 8 weeks
sensation 2PD
Lasso di tempo: at 8 weeks
two-point discrimination in the fingertip
at 8 weeks
extension lag
Lasso di tempo: at 2, 4, 6, 8, 12 weeks
extension lag in the PIP and DIP
at 2, 4, 6, 8, 12 weeks
length of incision
Lasso di tempo: at 3 months
length of incision in cm
at 3 months
pain at rest
Lasso di tempo: from day 3 after surgery until 3 months after surgery
Visual Analogue Scale from 0 to 10. 0 = no pain at all; 10 = the worst pain
from day 3 after surgery until 3 months after surgery
skin healing
Lasso di tempo: at 2, 3, 4, weeks
Healing scored according to the Surgical Wound Assessment Tool leading to a score between 0 and 39. 0 = the best score and 39 the worst.
at 2, 3, 4, weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Anders Björkman, MD, PhD, Göteborg University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 giugno 2026

Completamento primario (Stimato)

1 giugno 2028

Completamento dello studio (Stimato)

1 giugno 2028

Date di iscrizione allo studio

Primo inviato

12 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

12 maggio 2026

Primo Inserito (Effettivo)

19 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

19 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • Dnr 2026-00708-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

I don't see why this would be necessary and it is probably not allowed by my ethical authority.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi